Patents by Inventor Timothy N. Linnet

Timothy N. Linnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rutaecarpine derivatives for activating CYP1A2 in a subject
    Patent number: 8669264
    Abstract: The teachings provided herein generally relate to compositions comprising rutaecarpine derivatives that activates CYP1A2 through enzyme induction. The uses for such a derivative can include removing caffeine from a subject, improving sleep, treating insomnia, treating caffeine toxicity, treating caffeine addiction and withdrawal symptoms, and the like. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: March 11, 2014
    Assignee: Linnet Biopharmaceuticals, Inc.
    Inventors: Liang Xue, William K. Chan, Stan W. Linnet, Timothy N. Linnet
  • RUTAECARPINE DERIVATIVES FOR ACTIVATING CYP1A2 IN A SUBJECT
    Publication number: 20120322816
    Abstract: The teachings provided herein generally relate to compositions comprising rutaecarpine derivatives that activates CYP1A2 through enzyme induction. The uses for such a derivative can include removing caffeine from a subject, improving sleep, treating insomnia, treating caffeine toxicity, treating caffeine addiction and withdrawal symptoms, and the like. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 20, 2012
    Inventors: LIANG XUE, William K. Chan, Stan W. Linnet, Timothy N. Linnet
  • RUTAECARPINE DERIVATIVES FOR TREATING INSOMNIA
    Publication number: 20120322812
    Abstract: The teachings provided herein generally relate to compositions comprising a rutaecarpine derivative that activates CYP1A2 through enzyme induction. The uses for such a derivative, in some embodiments can include improving sleep, as well as treating insomnia. Other uses for the derivatives are provided herein.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 20, 2012
    Inventors: Stan W. Linnet, Timothy N. Linnet, William K. Chan, Liang Xue
  • RUTAECARPINE DERIVATIVES FOR TREATING CAFFEINE TOXICITY
    Publication number: 20120322813
    Abstract: The teachings provided herein generally relate to compositions comprising a rutaecarpine derivative that activates CYP1A2 through enzyme induction. The compound can be used for treating caffeine toxicity, in some embodiments. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 20, 2012
    Inventors: Timothy N. Linnet, Stan W. Linnet, William K. Chan, Liang Xue